Skip to main content

Table 3 Central foveal thickness as seen on OCT

From: Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

 

Mean baseline CFT (μm)

Mean 2-year CFT (μm)

Mean change (μm)

% Thickness change (%)

p value

TT

265

244

−21

−8.0

p = 0.001

TTZ

287

232

−55

−19.2

p < 0.0001

  1. TT triple combination therapy, TTZ triple combination therapy with zeaxanthin, CFT central foveolar thickness
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us